Andrew J. Epstein, PhD
Articles
July 17th 2019
Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug Adherence
Commercial health plan initiation of a co-pay accumulator adjustment program for specialty medications treating autoimmune diseases was associated with significant reductions in medication adherence and persistence.
January 23rd 2014
The Effects of Federal Parity on Substance Use Disorder Treatment
Susan H. Busch, PhD Andrew J. Epstein, PhD Michael O. Harhay, MPH David A. Fiellin, MD Hyong Un, MD Deane Leader Jr, DBA, MBA Colleen L. Barry, PhD, MPP
Federal parity led to an increase in spending on substance use disorder treatment.
Latest Updated Articles
Published: January 16th 2025 | Updated: January 29th 2025
FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
